Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Phase Ib Study Design Evaluating The Safety, Pharmacokinetics And Pharmacodynamics Of Selnoflast, A Novel NLRP3 Inflammasome Inhibitor In Early-Stage PD

              Author:D'Urso, Giulia   Thomann, Alessandra   Anzures-Cabrera, Judith   Zinnhardt, Bastian   Ricci, Benedicte   Bailey, Lorna   Smigorski, Krzysztof   Machado, Venissa   Mracskó, Eva Zsuszsanna   Pavese, Nicola   Marek, Kenneth   Brockmann, Kathrin   Simuni, Tanya   Milani Muelhardt, Nicoletta   Pagano, Gennaro   

              Session Name:P2: Movement Disorders: Clinical Trials in Parkinson's Disease 2  

              Topic:Movement Disorders  

              Program Number:P2.007  

              Author Institution:F. Hoffmann - La Roche Ltd, Basel, Switzerland  F. Hoffmann-La Roche Ltd, Welwyn Garden City, United Kingdom  Newcastle University, Newcastle upon Tyne, England, United Kingdom  Invicro, A Konica Minolta Company, Boston, MA  University Hospital Tuebingen, Tubingen, Germany  Northwestern University Feinberg School of Medicien, Chicago, IL